Hepatitis C is a blood-borne, infectious disease of the liver, which can lead to serious liver disease. Of those exposed to the hepatitis C virus (HCV), approximately 75-85% will develop chronic infection, about 60-70% will develop chronic liver disease, and up to 20% will develop cirrhosis if their HCV infection remains untreated (1). The majority of people with chronic HCV are not aware of their infection because signs and symptoms typically do not develop until the disease is advanced. While effective treatments are available, the lack of diagnosis is a great barrier to treatment.

<
About HepatitisC
Click here to learn more about the impact
Hepatitis C has on your patient and their families
  • Disease Burden
  • Transmission and Risk Factors
  • Importance of Testing and Linking to Care
  • Who Should be Tested for Hep C
  • Testing for Hep C
  • Treatment Options
Review of the WHO Guidelines for the Screening, Care, and Treatment of Persons with HCV

Speaker: Raj Reddy, MD
University of Pennsylvania
Philadelphia, PA
Hepatitis C Epidemiology and Disease Burden
Speaker: Robert Brown, MD
Columbia University Medical Center
New York, NY
Hepatitis C Testing, Diagnosis, & Linkage to Care
Speaker: Robert Brown, MD
Columbia University Medical Center
New York, NY
Hepatitis C Screening, Diagnosis, and Management for Primary Care Practices